JD Health International Inc
HKEX:6618
Intrinsic Value
JD Health International, Inc. operates as an online healthcare platform and retail pharmacy company. [ Read More ]
The intrinsic value of one
JD Health International Inc
stock under the Base Case scenario is
31.84
HKD.
Compared to the current market price of 24.2 HKD,
JD Health International Inc
is
Undervalued by 24%.
JD Health International Inc's market capitalization is 77B HKD.
JD Health International Inc stock price is 24.2 HKD.
JD Health International Inc stock price (24.2 HKD) is 24% less than its Intrinsic Value (31.84 HKD).
JD Health International Inc stock price (24.2 HKD) is 34% less than its DCF Value (36.91 HKD). Open DCF Valuation
JD Health International Inc stock price (24.2 HKD) is 10% less than its Relative Value (26.77 HKD). Open Relative Valuation
JD Health International Inc has upside potential of 87% compared to the average analyst price target.
Open Wall St Estimates
JD Health International Inc's Revenue has grown by 15% over the past 12 months.
JD Health International Inc's ROIC (Return on Invested Capital) for the past 12 months is positive and is equal to 17%.
JD Health International Inc's ROE (Return on Equity) for the past 12 months is very low and is equal to 5%.
JD Health International Inc has positive Gross Profit for the last twelve months.
JD Health International Inc's Revenue is forecast to grow at a rate of 17% per year over the next 3 years.
JD Health International Inc has positive Operating Income for the last twelve months.
JD Health International Inc has positive Free Cash Flow for the last twelve months.
JD Health International Inc's ROE (Return on Equity) has significantly increased in the last 3 years from -44% to 5%.
JD Health International Inc's ROIC (Return on Invested Capital) has significantly decreased in the last 3 years from 51% to 17%.
JD Health International Inc has positive Net Income for the last twelve months.
JD Health International Inc's Revenue has been growing by an exceptional 40% per year for the last 3 years.
JD Health International Inc has negative three-year average ROE (Return on Equity): -16%. The company is not efficient at transforming stockholders' equity into net income.
JD Health International Inc's D/E (Debt to Equity) is very low and is equal to 0.
JD Health International Inc has negative three-year average ROIC (Return on Invested Capital): -181%. The company is not efficient at using invested capital to generate operating income.
JD Health International Inc's short-term assets (56B CNY) exceed its short-term liabilties (13B CNY).
JD Health International Inc's long-term assets (61B CNY) exceed its long-term liabilties (13B CNY).
JD Health International Inc has negative Net Debt. This means that the company has more cash and short-term investments (48B CNY) than debt (133m CNY).
JD Health International Inc's Altman Z-Score is very high and is equal to 6.51.
JD Health International Inc earns more than enough operating income (894m CNY) to safely cover interest payments on its debt (9m CNY).
Valuation Backtest
JD Health International Inc
Run backtest to discover the historical profit from buying and selling
JD Health International Inc
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
JD Health International Inc
Balance Sheet Decomposition
JD Health International Inc
| Current Assets | 56.5B |
| Cash & Short-Term Investments | 48.5B |
| Receivables | 829.1m |
| Other Current Assets | 7.2B |
| Non-Current Assets | 4.9B |
| Long-Term Investments | 1.6B |
| PP&E | 757.7m |
| Intangibles | 2.3B |
| Other Non-Current Assets | 267.6m |
| Current Liabilities | 12.5B |
| Accounts Payable | 8.3B |
| Accrued Liabilities | 296.7m |
| Other Current Liabilities | 3.9B |
| Non-Current Liabilities | 154.5m |
| Long-Term Debt | 132.6m |
| Other Non-Current Liabilities | 21.9m |
Earnings Waterfall
JD Health International Inc
|
Revenue
|
53.5B
CNY
|
|
Cost of Revenue
|
-41.7B
CNY
|
|
Gross Profit
|
11.9B
CNY
|
|
Operating Expenses
|
-11B
CNY
|
|
Operating Income
|
894.4m
CNY
|
|
Other Expenses
|
1.2B
CNY
|
|
Net Income
|
2.1B
CNY
|
Free Cash Flow Analysis
JD Health International Inc
What is Free Cash Flow?
Profitability Score
Profitability Due Diligence
JD Health International Inc's profitability score is 40/100. The higher the profitability score, the more profitable the company is.
Score
JD Health International Inc's profitability score is 40/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
JD Health International Inc's solvency score is 99/100. The higher the solvency score, the more solvent the company is.
Score
JD Health International Inc's solvency score is 99/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
JD Health International Inc
According to Wall Street analysts, the average 1-year price target for
JD Health International Inc
is 45.16 HKD
with a low forecast of 24.95 HKD and a high forecast of 68.25 HKD.
Shareholder Return
Price
JD Health International Inc
| Average Annual Return | -3.28% |
| Standard Deviation of Annual Returns | 49.55% |
| Max Drawdown | -88% |
| Market Capitalization | 76.2B HKD |
| Shares Outstanding | 3 189 120 000 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
JD Health International Inc
Country
Industry
Market Cap
Dividend Yield
Description
JD Health International, Inc. operates as an online healthcare platform and retail pharmacy company. The company is headquartered in Beijing, Beijing. The company went IPO on 2020-12-08. The firm mainly providing pharmaceutical and healthcare products and Internet healthcare, health management, intelligent healthcare solutions to the customers, as well as a variety of marketing services to the business partners. The firm mainly conducts its businesses in domestic market.
Contact
IPO
Employees
Officers
The intrinsic value of one
JD Health International Inc
stock under the Base Case scenario is
31.84
HKD.
Compared to the current market price of 24.2 HKD,
JD Health International Inc
is
Undervalued by 24%.
You don't have any saved screeners yet
